InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,870.62
(
-1.32%
)
US TECH 100
19,880.00
(
-2.30%
)
Dow Jones
43,444.99
(
-0.70%
)
Brent Oil
70.59
(
-0.93%
)
Bitcoin
89,364.88
(
-1.34%
)
Post# of 6072
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

damoney

Send PM Follow Ignore
Followers 2
Posts 335
Boards Moderated 0
Alias Born 11/04/2009

damoney

Re: errett post# 2546

Monday, 05/07/2012 5:20:14 PM

Monday, May 07, 2012 5:20:14 PM

Post# of 6072
Per the statement from TLON, "We will continue to work collaboratively with the FDA during this review process and will continue on-going label negotiations," stated Steven R. Deitcher MD, President, Chief Executive Officer and Board Member of Talon Therapeutics. "In addition, we will continue to conduct our Phase 3 confirmatory trial, which received Special Protocol Assessment agreement from the FDA, in front-line adult elderly ALL," Dr. Deitcher added.
Sounds like it may only be a labeling issue? Is it possible to receive a decision prior to the end of the 90 day extension?
Still holding and may add if the price is right.
GLTA
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up